Restore Mind Medicine
Board Fails to Hold
Management Accountable
The Board, whose members collectively
own 0.22% of MindMed shares, has:
Not held management accountable
Demonstrated no real accountability to shareholders
Little alignment with shareholders by owning the least amount
of shares in their peer group
The Board has continued to lavish executives with substantial compensation,
while executives have overseen a parade of operational failures.
The Board believes that MindMed should stay-the-course and not implement
substantive change.
The Board is the highest paid of their peer group, despite having the worst
performance in 2022 of its peer group.
Despite the Company's continuing underperformance Chair Vallone and Vice-
Chair Krebs received a combined $2M in 2022.
Source: Company SEC Filings. See [8]
×
16View entire presentation